MIRA INFORM REPORT

 

 

Report Date :

21.12.2013

 

IDENTIFICATION DETAILS

 

Name :

RENOWN PHARMACEUTICALS PRIVATE LIMITED (w.e.f.13.10.2009)

 

 

Formerly Known As :

RENOWN CERATEK PRIVATE LIMITED

 

 

Registered Office :

4, Nikunj Appartment, Behind Jaldhara Complex, Vasna Road, Vadodara – 390015, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

05.09.2005

 

 

Com. Reg. No.:

04-046714

 

 

Capital Investment / Paid-up Capital :

Rs. 40.000 Millions

 

 

CIN No.:

[Company Identification No.]

U24230GJ2005PTC046714

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDR01348E

 

 

PAN No.:

[Permanent Account No.]

AADCR0916L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Soft Gelatin Capsules for Medicinal and Non-Medicinal Uses.

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Maximum Credit Limit :

USD 590000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

Latest financial of 2013 is not available with us.

 

As claimed by Mr. Malay Trivedi, Accounts Manager that the company has achieved turnover of 119.900 Millions in the year 2013, which is not verified.

 

As per of 2012, company has changed its line of business from operation and maintenance contract of gas engine to manufacturing soft gelatin capsules for medicinal and non-medicinal uses. It has incurred loss from its operation.

 

However, trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealings with some caution.   

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The current downturn provides an opportunity to push ahead with reforms to accelerate growth, says the latest India Development Update report released by the World Bank. The report says that the adverse effects of rupee depreciation are likely to be offset by the gains in the exports performance due to improved external competitiveness. Since May this year, the local currency has depreciated substantially and fell to a record level of Rs 68.85 to a dollar on August, 28.

 

A stagflation like situation appears to have arisen as inflation jumped to an eight month high of 6.46 % for the month of September. It is up from 6.10 % in August. Growth continues to be muted with factory output plunging to 0.6 % in August. Onion prices have risen nearly 300 % from last September. Vegetables cost nearly 90 % more than they did last year. Wake up to the economic contribution of slum dwellers. They contribute more than 7.5 % to the country’s gross domestic product, according to a recent study conducted in 50 top cities.

 

136000 estimated number of jobs created during the second quarter of the current financial year. 50000 estimated number of additional jobs in the field of corporate social responsibility in the coming years.

 

The International Finance Corporation expects to come out with its rupee linked bonds issue before the end of 2013 as a part of its plan to raise $ 1 billion. The Apple iPhone 5c (Rs 41900 for 16 GB variant) and 5s (Rs 53500 for 16GB variant) has been launched in India from 1st November.

 

The Land Acquisition Act to provide just and fair compensation to farmers will come into force from January 1 next year, said Rural Development Minister Jairam Ramesh. The Act replaces a 119 year old registration. The Securities and Exchange Board of India has approved the trading of currency futures on the Bombay Stock Exchange. The exchange plans to launch the currency futures platform with advanced trading technology by the end of November.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term bank facilities : B

Rating Explanation

Risk prone credit quality and very high credit risk

Date

March 5, 2013

 

 

Rating Agency Name

CARE

Rating

Short term bank facilities : A4

Rating Explanation

Minimal degree of safety and very high credit risk.

Date

March 5, 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Malay Trivedi

Designation :

Accounts Manager

Contact No.:

91-2662-244131

Date :

19.12.2013

 

 

LOCATIONS

 

Registered Office :

4, Nikunj Appartment, Behind Jaldhara Complex, Vasna Road, Vadodara – 390015, Gujarat, India

Tel. No.:

91-265-2250511

Fax No.:

91-265-2250611

E-Mail :

info@renownpharma.com

malaytrvedi@renownpharma.com 

marketing@renownpharma.com

Website :

renownpharma.com

Location :

Owned

 

 

Corporate and Manufacturing Unit :

Survey No. 143/A and B, Village Ranu, Taluka Padra, District Vadodara – 341445, Gujarat, India

Tel. No.:

91-2662-244131/ 32/ 33/ 34

Fax No.:

hr1@renownpharma.com

jaswinderanand@renownpharma.com

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Ramesh Subhkaran Jatia

Designation :

Managing director

Address :

148/1, Near Visa Court Apartment, Sayed Vasana Road Vadodara – 390015, Gujarat, India 

Date of Birth/Age :

04.10.1960

Date of Appointment :

31.12.2009

DIN No.:

00008298

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

L26921GJ1985PLC008196

BELL CERAMICS LIMITED

Whole-time director

01/01/2007

28/05/1991

30/03/2008

Amalgamated

NO

2

L55101DL1980PLC011037

ASIAN HOTELS (NORTH) LIMITED

Director

28/11/1992

28/11/1992

07/11/2013

Active

NO

3

U70100GJ1996PTC030853

DEEPAK GARDEN FRESH PRIVATE LIMITED

Director

01/02/1999

01/02/1999

29/03/2009

Active

NO

4

U55101MH2005PTC151196

GRANDEOUR HOTELS PRIVATE LIMITED

Director

10/02/2005

10/02/2005

01/09/2010

Active

NO

5

U51109GJ2007PTC050708

GLORIOUS TRADING PRIVATE LIMITED

Director

01/05/2007

01/05/2007

-

Active

NO

6

U55100MH2005PTC157086

JATIA HOTELS & RESORTS PRIVATE LIMITED

Additional director

17/01/2008

17/01/2008

28/01/2008

Amalgamated

NO

7

U26914GJ2008PTC052999

ROBUST CERATECH PRIVATE LIMITED

Director

21/02/2008

21/02/2008

-

Active

NO

8

U26933GJ2004PLC043426

ADVATECH CERA TILES LIMITED

Managing director

20/08/2008

10/07/2008

07/10/2009

Active

NO

9

U26933GJ2008PLC054520

NAUMEE CERAMICA INDIA LIMITED

Director

21/07/2008

21/07/2008

-

Active

NO

10

U24230GJ2005PTC046714

RENOWN PHARMACEUTICALS PRIVATE LIMITED

Managing director

31/12/2009

31/12/2009

-

Active

NO

 

 

Name :

Mr. Satish Duggappa Bangera

Designation :

Director

Address :

803, Gambs Tower, Near Good Shepards Church Four Bunglows, Juhu Link Road, Andheri West Mumbai – 400058, Maharashtra, India 

Date of Birth/Age :

23.10.1959

Date of Appointment :

31.12.2009

DIN No.:

05177377

 

 

Name :

Mr. Katapady Raghuveer Katapady Gunduraya Bhat

Designation :

Director

Address :

8/8, Shivagi Nagar, Opposite Glaxo Labs, Dr. A B Road, Worli Mumbai – 400025, Maharashtra, India 

Date of Birth/Age :

19.07.1940

Date of Appointment :

31.12.2009

DIN No.:

02902754

 

 

Name :

Mr. Atishay Ramesh Jatia

Designation :

Director

Address :

148/1, Near Visa Court Apartment, Sayed Vasana Road Vadodara – 390015, Gujarat, India 

Date of Birth/Age :

18.09.1987

Date of Appointment :

28.09.2007

DIN No.:

02315891

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ2005PTC046714

RENOWN PHARMACEUTICALS PRIVATE LIMITED

Director

28/09/2007

28/09/2007

Active

NO

2

U70100GJ1996PTC030853

DEEPAK GARDEN FRESH PRIVATE LIMITED

Additional director

29/03/2009

29/03/2009

Active

NO

3

U55204GJ2012PLC070465

RENOWN HOSPITALITY LIMITED

Director

25/05/2012

25/05/2012

Active

NO

 

 

Name :

Mrs. Smita Rameshkumar Jatia

Designation :

Director

Address :

148/1, Near Visa Court Apartment, Sayed Vasana Road Vadodara – 390015, Gujarat, India 

Date of Birth/Age :

23.11.1963

Date of Appointment :

05.09.2005

DIN No.:

00510718

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U70100GJ1996PTC030853

DEEPAK GARDEN FRESH PRIVATE LIMITED

Whole-time director

01/02/1999

01/02/1999

-

Active

NO

2

U24230GJ2005PTC046714

RENOWN PHARMACEUTICALS PRIVATE LIMITED

Director

05/09/2005

05/09/2005

-

Active

NO

3

U55101MH2005PTC151196

GRANDEOUR HOTELS PRIVATE LIMITED

Director

10/07/2006

10/07/2006

20/02/2010

Active

NO

4

U26933GJ2004PLC043426

ADVATECH CERA TILES LIMITED

Director

01/03/2007

01/03/2007

10/07/2008

Active

NO

5

U51109GJ2007PTC050708

GLORIOUS TRADING PRIVATE LIMITED

Director

01/05/2007

01/05/2007

-

Active

NO

6

U55100MH2005PTC157086

JATIA HOTELS & RESORTS PRIVATE LIMITED

Director

26/09/2008

28/08/2008

20/02/2010

Amalgamated

NO

7

U55204GJ2012PLC070465

RENOWN HOSPITALITY LIMITED

Director

25/05/2012

25/05/2012

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Malay Trivedi

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Names of Shareholders

 

No. of Shares

 

Smita Ramesh Jatia

 

2117000

Kamal K Sethia

 

2500

Satish Dugappa Bangera

 

55797

Addison Holding Limited, Dubai

 

1040739

Ramesh Subhkaran Jatia

 

390000

Atishay Ramesh Jatia

 

100000

Ankita Ramesh Jatia

 

75000

Ramesh Subhkaran Jatia (HUF)

 

374293

 

 

 

Total

 

 

4155329

 

 

AS ON 30.09.2013

 

Equity Share Breakup

Percentage of Holding

Category

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

25.00

Directors or relatives of directors

75.00

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Soft Gelatin Capsules for Medicinal and Non-Medicinal Uses.

 

 

Exports :

 

Products :

Finished Goods 

Countries :

·         UK

Vietnam

Israel

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Customers :

Others

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

·         State Bank of India, Mid Corporate Group Industrial Finance Branch, Marble Acrch, Race Course Circle, Vadodara - 390007, Gujarat, India

 

Shree Vardhman Co-operative Bank Limited

HDFC Bank Limited

 

 

Facilities :

 

SECURED LOANS

31.03.2012

(Rs. In Millions)

31.03.2011

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

From State Bank of India - Term Loan for New Project at Ranu

295.736

35.375

From Shree Vardhman Co-Operative Bank - Term Loan against Gas Engine

{Repayable in 60 equated monthly installments of Rs. 0.160 Million each including interest, starting from 18/11/2010.}

4.157

5.412

From HDFC Bank (Car Loan)

{Repayable in 60 equated monthly installments of Rs. 0.013 Million each including interest, starting from 19/12/2009.}

0.233

0.359

SHORT TERM BORROWINGS

 

 

Working Capital Loan - From State Bank of India (Cash Credit)

1.968

0.000

 

 

 

Total

 

302.094

41.146

 

 

LONG-TERM BORROWINGS

 

Security :

Secured against the entire Factory Land, Building, Plant and Machineries, Equipments and other Fixed Assets of the Company of its new project at Ranu, Gujarat. The funding is further secured by personal guarantees of three directors of the Company as well Second Charge on Residential Property of the Managing Director and pledging of equity shares of listed companies held by the Managing Director.

 

Rate of Interest :

0.25% above SBAR i.e. present effective rate of 12% p.a. with money rest and annual reset.

 

Repayment Schedule :

Year

No. of Installments

Inst. Amount (Rs. In Millions)

Total Amount (Rs. In Millions)

2012-13

12

1.750

21.000

2013-14

12

2.500

30.000

2014-15

12

5.000

60.000

2015-16

12

5.000

60.000

2016-17

12

5.000

60.000

2017-18

12

5.000

60.000

2018-19

2

10.000

20.000

 

1

9.000

9.000

Total

75

 

320.000

 

 

Shree Vardhman Cooperative Bank Term Loan :

Term Loan from Vardhman Sahakari Bank Limited is secured against hypothecation of Gas Engine owned by the Company. The same is further secured by personal guarantees of two of the Directors and three relatives of Directors.

 

SHORT TERM BORROWINGS

 

Working Capital Loan :

 

Working Capital Loan from SBI is Cash Credit facility, repayable on demand, and secured by way of Hypothecation over entire Current Assets of the Company including Stocks and Receivables at Factory Premises. Personal Guarantees and Collateral Security as per Term Loan. Cash Credit Limit capped at Rs. 30.000 Millions upto 31st March, 2012. Interest Payable @ 4% above base rate at monthly rests (effective rate at time of section being 14%)

 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Naresh and Company

Chartered Accountants

Address :

201-203,City Enclave, Opposite Polo Ground, Bagikhana, Vadodara – 390001, Gujarat, India

Income-tax PAN of auditor or auditor's firm :

AACFM7595C

 

 

Enterprise over which Key Management Persons have significant influence :

·         Deepak Garden Fresh Private Limited

Naumee Ceramica India Limited

Glorious Trading Private Limited

Robust Ceratech Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,000,000

Equity Shares

Rs. 10/- each

Rs. 50.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4,155,329

Equity Shares

Rs. 10/- each

Rs. 41.553 Millions

 

 

 

 

 

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,000,000

Equity Shares

Rs.10/- each

Rs.50.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4,000,000

Equity Shares

Rs.10/- each

Rs.40.000 Millions

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

40.000

28.663

(b) Reserves & Surplus

 

108.685

80.990

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

148.685

109.653

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

345.439

88.818

(b) Deferred tax liabilities (Net)

 

20.476

1.813

(c) Other long term liabilities

 

2.106

2.106

(d) long-term provisions

 

0.253

0.054

Total Non-current Liabilities (3)

 

368.274

92.791

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

1.968

0.000

(b) Trade payables

 

6.228

2.146

(c) Other current liabilities

 

76.492

55.122

(d) Short-term provisions

 

0.243

0.651

Total Current Liabilities (4)

 

84.931

57.919

 

 

 

 

TOTAL

 

601.890

260.363

 

 

 

 

II.    ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

512.804

14.772

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

203.438

(iv) Intangible assets under development

 

0.127

0.000

(b) Non-current Investments

 

0.212

0.212

(c) Deferred tax assets (net)

 

20.476

0.000

(d)  Long-term Loan and Advances

 

11.545

15.934

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

545.164

234.356

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.367

0.202

(b) Inventories

 

9.592

0.000

(c) Trade receivables

 

2.806

0.815

(d) Cash and cash equivalents

 

0.887

0.601

(e) Short-term loans and advances

 

43.047

24.389

(f) Other current assets

 

0.027

0.000

Total Current Assets

 

56.726

26.007

 

 

 

 

TOTAL

 

601.890

260.363

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

19.195

2] Share Application Money

 

 

8.445

3] Reserves & Surplus

 

 

5.889

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

33.529

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

3.847

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

3.847

DEFERRED TAX LIABILITIES

 

 

1.637

 

 

 

 

TOTAL

 

 

39.013

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

14.892

Capital work-in-progress

 

 

14.231

 

 

 

 

INVESTMENT

 

 

2.107

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

0.000

 

Sundry Debtors

 

 

0.815

 

Cash & Bank Balances

 

 

1.514

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

13.175

Total Current Assets

 

 

15.504

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

3.438

 

Other Current Liabilities

 

 

3.781

 

Provisions

 

 

0.502

Total Current Liabilities

 

 

7.721

Net Current Assets

 

 

7.783

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

39.013

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Turnover

5.824

9.048

9.038

 

 

Other Income

1.879

1.679

NA

 

 

TOTAL                                     (A)

7.703

10.727

NA

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

TOTAL                                     (B)

26.460

5.420

NA

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

(18.757)

5.307

NA

 

 

 

 

 

 

FINANCIAL EXPENSES                         (D)

5.792

0.856

NA

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

(24.549)

4.451

NA

 

 

 

 

 

 

DEPRECIATION/ AMORTISATION                     (F)

3.153

1.069

NA

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                 (G)

(9.812)

3.382

3.214

 

 

 

 

 

 

TAX                                                                  (H)

1.812

0.827

0.722

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

(7.999)

2.556

2.492

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Capital Goods

4.142

16.680

0.000

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(2.62)

1.25

1.29

 

 

Particulars

 

 

 

31.03.2013

Sales Turnover (Approximately)

 

 

119.900

 

 

 

[Good business done by company]

 

 

The above information has been parted by Mr. Malay Trivedi (Accounts Manager)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

(103.84)

23.83

NA

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(168.48)

37.38

35.56

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(1.69)
5.96

10.57

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.07)
0.03

0.10

 

 

 
 

 

Debt Equity Ratio

(Total Debt/Networth)

 

2.34
0.81

0.11

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

0.67
0.45

2.01

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

Yes

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10305281

08/10/2013 *

418,000,000.00

STATE BANK OF INDIA

MID CORPORATE GROUP INDUSTRIAL FINANCE BRANCH, MARBLE ACRCH, RACE COURSE CIRCLE, VADODARA - 390007, GUJARAT, INDIA

B87105227

2

10300543

28/10/2010

7,000,000.00

SHREE VARDHAMAN SAHAKARI BANK LIMITED

NEAR TARKESHWAR MAHADEV, RAOPURA, BARODA - 390001, GUJARAT, INDIA

B08626947

3

10248102

08/10/2013 *

418,000,000.00

STATE BANK OF INDIA

MID CORPORATE GROUP INDUSTRIAL FINANCE BRANCH, MARBLE ACRCH, RACE COURSE CIRCLE, VADODARA - 390007, GUJARAT, INDIA

B90663386

 

* Date of charge modification

 

 

UNSECURED LOANS

 

UNSECURED LOANS

31.03.2012

(Rs. In Millions)

31.03.2011

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Inter Corporate Deposits

5.762

3.689

From Directors

12.963

12.523

From Members & Relatives

6.588

0.460

Others :

 

 

Inter Corporate Deposits

20.000

31.000

 

 

 

Total

 

45.313

47.672

 

LONG-TERM BORROWINGS

 

Unsecured Loans :

 

The amount taken as unsecured loans viz Inter-Corporate Borrowing and Loans from Directors and Members are usually payable on demand but the company reserves its right to defer the payment of the same for a period exceeding 12 months. Also these loans have been treated as part of Promoters Contribution for the Term Loan from SBI and hence are not repayable in the short run.

 

Interest has been paid on Inter Corporate Deposits @ 12% / 14%

 

No interest has been paid on the unsecured loans taken from Directors and Members as per the requirement of SBI Term Loan whereby no such interest is to be paid till repayment of the Term Loan.

 

 

CHANGE OF ADDRESS:

 

The registered office of the company has been shifted from 1/148 Vasna Road, Off Old Padra Road, Vadodara - 390015, Gujarat, India to present address w.e.f. 07.09.2009

 

 

FINANCIAL RESULTS

 

As you might be aware Company has ventured into the business of pharmaceuticals and neutraceuticals, beginning with manufacturing soft gelatin capsules for medicinal and nonmedicinal uses. Company had completed the change of name and objects and re-shuffling / broadbasing of the Board of Directors during the earlier year. Thereafter Company had acquired Land and started construction of a state-of-the-art manufacturing facilities. The Project Cost was expected to be around Rs. 500.000 Millions. Tie-up was made with an overseas entity which has acquired strategic stake in our Company at a premium to part fund the project cost. Necessary borrowing arrangements have been made with State Bank of India for additional funding.

 

The setup work for the manufacturing facility continued in full-swing. However, due to certain delays in obtaining NA permission for land resulted in few delays in the expected time lines. As a result construction work spilled over to the year. As per revised targets the setup of the manufacturing facility was completed during the year with trail production commencing from October, 2011 and commercial production starting from March 2012. Company has presently started operating two manufacturing lines with a third line possible to be installed subsequently. The coming year will be the first full fledge year of operations for the pharmaceutical business.

 

For the year, the company achieved a turnover of Rs. 2.598 Millions from manufacturing of soft-gel capsules in March 2012 being the first full month of operations. Also Company had revenues of Rs. 3.770 Millions from the Operation and Maintenance Contract of their Gas Engine. The five-year contract expired this year and the engine has been sent for maintenance resulting in lower annual revenue on this front. All in all they achieved a turnover of Rs. 5.824 Millions. However considering the finance costs and other expenses (even after capitalisation of proportionate portions to the project) and the heavy depreciation charge resulted in a net loss of almost Rs. 8.000 Millions including cash losses.

 

The Company will start revenue generation from the manufacturing business in the current year since it will be a full year of operations with full scale of operations being achieved. The order pipeline is also good. Company has also taken many important accreditations such as WHO GMP and is also in process of taking country / continent based approvals. Some approvals may cause some delays but all in all with good demand position , the Company should be able to achieve a healthy turnover and should be able to generate cash surpluses though the net result might still be negative on account of the expected heavy initial depreciation charge.

 

All in all they expect this year to be a take-off year for the Company on a firm path of growth and progress.

 

 

GENERAL INFORMATION OF THE COMPANY

 

Subject is a Vadodara, Gujarat, India based Company presently engaged in the business of manufacturing of soft gelatin capsules for medicine and non-medicinal uses.

 

The Company was incorporated in the year 2005 originally as “Renown Ceratek Private Limited” in order to undertake the business of manufacturing and dealing in Ceramic Tiles. In the initial few years there were no major business activities undertaken and the only revenues were from leasing of a Gas Engine. Subsequently, in the year 2009-10, after making business viability study, the management proposed to pursue the business of pharmaceuticals and neutraceuticals, principally manufacturing of soft gelatin capsules to begin with for medicinal and non-medicinal uses, mostly on contract manufacturing basis.

 

Consequently in the Extra Ordinary General Meeting of the Members held on 4th August, 2009, the Shareholders approved the change in the Main Objects of the Company from ceramic business to said pharmaceutical business. Further to the change in the main objects of the Company, the Management also decided to change the name of the Company to accurately and correctly reflect the new objects of the Company. Accordingly, in the Annual General Meeting of the Company held on 15th September, 2009, the Shareholders of the Company approved the change in the name of the Company to Renown Pharmaceuticals Private Limited. The change was approved by the Office of the Registrar of Companies, Gujarat by way of grant of certificate dtd. 13th October, 2009.

 

Post the Change of Objects and Name as aforesaid, the Company acquired Land and started construction of a new plant. The Construction activity was completed during the year with the Company commencing its trial production from September, 2011. The total project cost exceeded Rs. 500.000 Millions and has been funded through Term Loans from Banks and Promoters Contributions and Foreign Direct Investment in the Company.

 

The Company has commenced its commercial production from March, 2012. Company has presently started operating two manufacturing lines with a third line possible to be installed subsequently. The coming year will be the first full fledge year of operations for the pharmaceutical business.

 

 

FIXED ASSETS:

 

·         Gas Engine

Land

Building

Furniture and Fixtures

Vehicle

Equipments

Other Equipments

Computer

Plant and Machinery

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 62.24

UK Pound

1

Rs. 101.81

Euro

1

Rs. 84.88

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.